Clinical trial
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada)
NCT05047302 is registered in ClinicalTrials.gov with Intervene, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada)
- Lead sponsor
- Intervene, Inc.
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 1, 2022
- Completion date
- November 1, 2026
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic venous insufficiency